 Craig Forester
Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematopoietic Stem Cells | 2 | 2024 | 420 | 0.580 |
Why?
| | Protein Biosynthesis | 5 | 2021 | 458 | 0.500 |
Why?
| | Anemia, Aplastic | 1 | 2015 | 42 | 0.430 |
Why?
| | Cell Differentiation | 2 | 2021 | 2050 | 0.410 |
Why?
| | Bone Marrow | 1 | 2015 | 306 | 0.390 |
Why?
| | Myelodysplastic Syndromes | 1 | 2015 | 147 | 0.390 |
Why?
| | Proteome | 1 | 2018 | 518 | 0.380 |
Why?
| | Cysts | 1 | 2012 | 111 | 0.340 |
Why?
| | cdc25 Phosphatases | 2 | 2007 | 13 | 0.330 |
Why?
| | Proteomics | 1 | 2018 | 1195 | 0.330 |
Why?
| | Skin Diseases | 1 | 2012 | 149 | 0.320 |
Why?
| | Immunosuppressive Agents | 1 | 2015 | 847 | 0.310 |
Why?
| | Mitosis | 2 | 2007 | 200 | 0.300 |
Why?
| | Cerebral Angiography | 1 | 2009 | 119 | 0.300 |
Why?
| | Protein Phosphatase 2 | 2 | 2007 | 41 | 0.280 |
Why?
| | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2009 | 89 | 0.280 |
Why?
| | CDC2 Protein Kinase | 1 | 2007 | 27 | 0.270 |
Why?
| | Signal Transduction | 2 | 2018 | 5233 | 0.220 |
Why?
| | Lung Diseases | 1 | 2012 | 787 | 0.220 |
Why?
| | Anemia, Diamond-Blackfan | 1 | 2024 | 1 | 0.220 |
Why?
| | GATA1 Transcription Factor | 1 | 2024 | 18 | 0.220 |
Why?
| | Brain Neoplasms | 2 | 2015 | 1322 | 0.210 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2018 | 451 | 0.210 |
Why?
| | Liver Neoplasms | 2 | 2019 | 783 | 0.180 |
Why?
| | Genetic Therapy | 1 | 2024 | 313 | 0.180 |
Why?
| | Haploinsufficiency | 1 | 2021 | 55 | 0.170 |
Why?
| | Ribosomal Proteins | 1 | 2021 | 91 | 0.170 |
Why?
| | Extremities | 1 | 2021 | 140 | 0.160 |
Why?
| | Pseudouridine | 1 | 2019 | 4 | 0.150 |
Why?
| | Anemia, Macrocytic | 1 | 2019 | 4 | 0.150 |
Why?
| | RNA, Ribosomal, 18S | 1 | 2019 | 27 | 0.150 |
Why?
| | RNA, Small Nuclear | 1 | 2019 | 38 | 0.150 |
Why?
| | Eye Abnormalities | 1 | 2019 | 17 | 0.150 |
Why?
| | Genes, Tumor Suppressor | 1 | 2019 | 83 | 0.150 |
Why?
| | Endopeptidases | 1 | 2019 | 82 | 0.150 |
Why?
| | Diagnosis, Differential | 2 | 2015 | 1495 | 0.150 |
Why?
| | Tomography, X-Ray Computed | 1 | 2009 | 2738 | 0.140 |
Why?
| | Kell Blood-Group System | 1 | 2018 | 1 | 0.140 |
Why?
| | alpha-Thalassemia | 1 | 2018 | 5 | 0.140 |
Why?
| | Craniofacial Abnormalities | 1 | 2019 | 76 | 0.140 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2019 | 92 | 0.140 |
Why?
| | Rh-Hr Blood-Group System | 1 | 2018 | 14 | 0.140 |
Why?
| | ras Proteins | 1 | 2019 | 151 | 0.140 |
Why?
| | Magnetic Resonance Imaging | 2 | 2019 | 3869 | 0.140 |
Why?
| | Protein Processing, Post-Translational | 1 | 2021 | 477 | 0.140 |
Why?
| | Isoantibodies | 1 | 2018 | 57 | 0.140 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2021 | 428 | 0.140 |
Why?
| | Puromycin | 1 | 2018 | 10 | 0.140 |
Why?
| | beta-Thalassemia | 1 | 2018 | 40 | 0.140 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2018 | 33 | 0.140 |
Why?
| | K562 Cells | 1 | 2018 | 93 | 0.140 |
Why?
| | Sciatic Nerve | 1 | 2018 | 60 | 0.130 |
Why?
| | Ganglia, Spinal | 1 | 2018 | 89 | 0.130 |
Why?
| | Carcinogenesis | 1 | 2019 | 229 | 0.130 |
Why?
| | Cell Cycle Proteins | 1 | 2021 | 629 | 0.130 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2021 | 531 | 0.130 |
Why?
| | Drug Discovery | 1 | 2018 | 155 | 0.120 |
Why?
| | Axons | 1 | 2018 | 201 | 0.120 |
Why?
| | Erythrocyte Transfusion | 1 | 2018 | 231 | 0.120 |
Why?
| | Chromatography, Liquid | 1 | 2018 | 454 | 0.120 |
Why?
| | Thioridazine | 1 | 2015 | 1 | 0.120 |
Why?
| | Survival Analysis | 2 | 2019 | 1385 | 0.120 |
Why?
| | Ether-A-Go-Go Potassium Channels | 1 | 2015 | 6 | 0.120 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2019 | 372 | 0.110 |
Why?
| | Tandem Mass Spectrometry | 1 | 2018 | 577 | 0.110 |
Why?
| | Clonal Evolution | 1 | 2015 | 47 | 0.110 |
Why?
| | RNA | 1 | 2021 | 940 | 0.100 |
Why?
| | Medical Records | 1 | 2015 | 189 | 0.100 |
Why?
| | Immunotherapy | 1 | 2019 | 657 | 0.100 |
Why?
| | Drug Delivery Systems | 1 | 2015 | 381 | 0.090 |
Why?
| | Mice | 7 | 2024 | 18365 | 0.090 |
Why?
| | Evolution, Molecular | 1 | 2015 | 515 | 0.080 |
Why?
| | Radiography, Thoracic | 1 | 2012 | 171 | 0.080 |
Why?
| | Up-Regulation | 2 | 2019 | 852 | 0.080 |
Why?
| | Prostatic Neoplasms | 1 | 2018 | 978 | 0.080 |
Why?
| | Humans | 14 | 2024 | 144957 | 0.080 |
Why?
| | Predictive Value of Tests | 1 | 2015 | 2118 | 0.070 |
Why?
| | Enzyme Activation | 2 | 2007 | 768 | 0.070 |
Why?
| | Osteosarcoma | 1 | 2009 | 76 | 0.070 |
Why?
| | Intracranial Hemorrhages | 1 | 2009 | 100 | 0.070 |
Why?
| | Ribosomes | 2 | 2021 | 191 | 0.070 |
Why?
| | Animals | 9 | 2024 | 38109 | 0.070 |
Why?
| | Mutation | 1 | 2019 | 4099 | 0.070 |
Why?
| | Cerebellum | 1 | 2009 | 223 | 0.070 |
Why?
| | Cerebellar Neoplasms | 1 | 2009 | 177 | 0.070 |
Why?
| | Bone Neoplasms | 1 | 2009 | 256 | 0.060 |
Why?
| | 14-3-3 Proteins | 1 | 2006 | 15 | 0.060 |
Why?
| | Xenopus Proteins | 1 | 2006 | 37 | 0.060 |
Why?
| | Xenopus | 1 | 2006 | 89 | 0.060 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2006 | 65 | 0.060 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2007 | 269 | 0.060 |
Why?
| | Surveys and Questionnaires | 1 | 2018 | 6053 | 0.060 |
Why?
| | Neoplasms | 1 | 2021 | 2884 | 0.060 |
Why?
| | Infant, Newborn | 2 | 2019 | 6434 | 0.060 |
Why?
| | Lentivirus | 1 | 2024 | 60 | 0.050 |
Why?
| | Erythropoiesis | 1 | 2024 | 57 | 0.050 |
Why?
| | Male | 7 | 2019 | 72406 | 0.050 |
Why?
| | Genetic Vectors | 1 | 2024 | 337 | 0.050 |
Why?
| | Female | 6 | 2019 | 78376 | 0.050 |
Why?
| | Cell Line | 1 | 2007 | 2882 | 0.040 |
Why?
| | Phenotype | 2 | 2021 | 3164 | 0.040 |
Why?
| | Protein Binding | 1 | 2007 | 2276 | 0.040 |
Why?
| | RNA Editing | 1 | 2021 | 26 | 0.040 |
Why?
| | Body Patterning | 1 | 2021 | 138 | 0.040 |
Why?
| | Treatment Outcome | 1 | 2015 | 11695 | 0.040 |
Why?
| | Eukaryotic Initiation Factor-4E | 1 | 2019 | 32 | 0.040 |
Why?
| | 5' Untranslated Regions | 1 | 2019 | 59 | 0.040 |
Why?
| | Rats, Inbred BB | 1 | 2018 | 5 | 0.030 |
Why?
| | Immune Evasion | 1 | 2019 | 64 | 0.030 |
Why?
| | Open Reading Frames | 1 | 2019 | 132 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2019 | 570 | 0.030 |
Why?
| | Unfolded Protein Response | 1 | 2018 | 60 | 0.030 |
Why?
| | Cell Size | 1 | 2018 | 92 | 0.030 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 253 | 0.030 |
Why?
| | Genetic Association Studies | 1 | 2019 | 373 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2018 | 397 | 0.030 |
Why?
| | Mutation, Missense | 1 | 2019 | 340 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2019 | 167 | 0.030 |
Why?
| | 3' Untranslated Regions | 1 | 2018 | 152 | 0.030 |
Why?
| | Retrospective Studies | 1 | 2015 | 17101 | 0.030 |
Why?
| | B7-H1 Antigen | 1 | 2019 | 241 | 0.030 |
Why?
| | Down-Regulation | 1 | 2019 | 627 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2019 | 966 | 0.030 |
Why?
| | Alleles | 1 | 2019 | 881 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2021 | 906 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2019 | 695 | 0.030 |
Why?
| | Phosphoproteins | 1 | 2018 | 346 | 0.030 |
Why?
| | Imaging, Three-Dimensional | 1 | 2019 | 583 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2024 | 2609 | 0.030 |
Why?
| | COS Cells | 1 | 2015 | 181 | 0.030 |
Why?
| | Base Sequence | 1 | 2019 | 2191 | 0.030 |
Why?
| | Pyrimidines | 1 | 2019 | 533 | 0.030 |
Why?
| | Child | 1 | 2015 | 22657 | 0.030 |
Why?
| | Pyridines | 1 | 2019 | 605 | 0.030 |
Why?
| | Genotype | 1 | 2019 | 1835 | 0.030 |
Why?
| | Tumor Microenvironment | 1 | 2019 | 735 | 0.030 |
Why?
| | Models, Molecular | 1 | 2019 | 1619 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2021 | 3125 | 0.030 |
Why?
| | Drosophila | 1 | 2015 | 166 | 0.030 |
Why?
| | RNA-Binding Proteins | 1 | 2018 | 464 | 0.030 |
Why?
| | Mice, Nude | 1 | 2015 | 688 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2015 | 919 | 0.020 |
Why?
| | Adolescent | 2 | 2009 | 22453 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2015 | 1253 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2019 | 1462 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2018 | 2540 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2019 | 1496 | 0.020 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2015 | 930 | 0.020 |
Why?
| | Models, Biological | 1 | 2019 | 1822 | 0.020 |
Why?
| | Disease Progression | 1 | 2019 | 2852 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2019 | 2365 | 0.020 |
Why?
| | Young Adult | 2 | 2019 | 14126 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2015 | 2185 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2018 | 2832 | 0.020 |
Why?
| | Rats | 1 | 2018 | 5614 | 0.020 |
Why?
| | Fatal Outcome | 1 | 2009 | 307 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2019 | 4569 | 0.020 |
Why?
| | Biomarkers | 1 | 2019 | 4275 | 0.020 |
Why?
| | Femur | 1 | 2009 | 250 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2019 | 5997 | 0.020 |
Why?
| | Phosphothreonine | 1 | 2006 | 6 | 0.020 |
Why?
| | Interphase | 1 | 2006 | 38 | 0.020 |
Why?
| | Intermediate Filaments | 1 | 2006 | 25 | 0.020 |
Why?
| | Checkpoint Kinase 1 | 1 | 2006 | 27 | 0.020 |
Why?
| | Holoenzymes | 1 | 2006 | 25 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2019 | 8279 | 0.020 |
Why?
| | HCT116 Cells | 1 | 2006 | 78 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2018 | 2197 | 0.020 |
Why?
| | Keratins | 1 | 2006 | 172 | 0.010 |
Why?
| | Protein Subunits | 1 | 2006 | 226 | 0.010 |
Why?
| | Adult | 2 | 2019 | 40506 | 0.010 |
Why?
| | Infant | 1 | 2019 | 10039 | 0.010 |
Why?
| | HeLa Cells | 1 | 2006 | 650 | 0.010 |
Why?
| | Protein Kinases | 1 | 2006 | 315 | 0.010 |
Why?
| | DNA Replication | 1 | 2006 | 251 | 0.010 |
Why?
| | Phosphorylation | 1 | 2006 | 1733 | 0.010 |
Why?
| | United States | 1 | 2018 | 15988 | 0.010 |
Why?
| | Aged | 1 | 2019 | 25947 | 0.010 |
Why?
| | Middle Aged | 1 | 2019 | 35928 | 0.010 |
Why?
|
|
Forester's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|